Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01856647 · ClinicalTrials.gov registry record

Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects

A clinical trial, sponsored by Rockefeller University.

Terminated
Registry status
1
Enrollment target

NCT01856647: Clinical Trial study, sponsored by Rockefeller University.

NCT01856647 is a clinical trial that was terminated before completion, run by Rockefeller University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01856647 was terminated before completion, sponsored by Rockefeller University.

TERMINATED
Registry status
1 participants
Enrollment target

Study Summary

Obesity is an insulin resistance-associated metabolic disorder which is a hallmark of and risk factor for type 2 diabetes and the metabolic syndrome, often linked to cardiovascular disease, certain cancers and inflammatory diseases.The phenotyping of subcutaneous adipose tissue (SAT) hematopoetic cells from obese subjects by flow cytometry, microscopy and gene expression will enable us to identify inflammation in this tissue and may help us to understand the causes and consequences of obesity in order to determine how these cells might be implicated in the initiation and/or progression of the aforementioned diseases.

Primary Outcome

Biomarkers for phenotyping a new type of leukocyte

Interventions

  • PROCEDURE Adipose tissue biopsy (fat biopsy)

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2013-02
Est. Completion 2015-12
Rockefeller University

117 total trials

Why NCT01856647 stopped before completion

NCT01856647 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Adipose tissue biopsy (fat biopsy) is the first listed.

NCT01856647 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01856647 about?

NCT01856647 is a clinical study titled "Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects". Obesity is an insulin resistance-associated metabolic disorder which is a hallmark of and risk factor for type 2 diabetes and the metabolic syndrome, often linked to cardiovascular disease, certain cancers and inflammatory diseases.The phenotyping of subcutaneous adipose tissue (SAT) hematopoetic ce...

What is the current status of trial NCT01856647?

This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-02. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01856647?

The interventions under investigation include: Adipose tissue biopsy (fat biopsy) (PROCEDURE).

Who is sponsoring clinical trial NCT01856647?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01856647, the US trial registry maintained by the National Library of Medicine. NCT01856647 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.